Next-Generation Personalized Injection System
Legal Citation
Summary of the Inventive Concept
A wearable, AI-powered injection device that integrates physiological parameter detection, genomic analysis, and real-time dosage adjustment for personalized medicine.
Background and Problem Solved
The original patent disclosed a supplementary device for attachment to an injection device, enabling dosage selection and detection. However, it was limited to mechanical coupling and lacked advanced features for personalized medicine. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to provide a more sophisticated and adaptive injection system.
Detailed Description of the Inventive Concept
The next-generation personalized injection system comprises a miniaturized injection module integrated with a sensor array to detect a patient's physiological parameters, such as glucose levels, blood pressure, and heart rate. The system is powered by an artificial intelligence algorithm that analyzes the patient's medical history, genomic data, and real-time physiological parameters to optimize the dosage and administration route. The system features interchangeable cartridges containing different medications, which are automatically detected and adapted to by the system. Additionally, the device includes a subcutaneous injection module with an integrated biosensor for continuous glucose level monitoring and automatic insulin administration. The handheld device also incorporates a microfluidic chip for real-time blood chemistry analysis and dosage adjustment.
Novelty and Inventive Step
The new claims introduce a paradigm shift in injection technology by integrating AI, genomic analysis, and real-time physiological parameter detection, making the original patent's mechanical coupling and dosage selection obsolete. The inventive concept's novelty lies in its ability to provide personalized medicine through advanced data analysis and adaptive dosage adjustment.
Alternative Embodiments and Variations
Alternative embodiments may include a smartphone app for remote monitoring and data analysis, a cloud-based platform for data storage and sharing, or a modular design allowing for easy upgrade and replacement of components. Variations may include different sensor arrays, AI algorithms, or medication cartridges tailored to specific medical conditions or patient populations.
Potential Commercial Applications and Market
The next-generation personalized injection system has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, personalized medicine, and pharmaceutical research. The market for such a system is vast, with potential applications in hospitals, clinics, and home care settings, as well as in the development of new medications and treatment protocols.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/3155 |
| A | A61 | A61M5/2033 |
| A | A61 | A61M2005/3126 |
| A | A61 | A61M2205/332 |
| A | A61 | A61M2205/3327 |
| A | A61 | A61M2205/3584 |
| A | A61 | A61M2205/52 |
| A | A61 | A61M2205/8206 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically injection systems and drug delivery devices with mechanical and electronic interfaces for dosage control and patient monitoring
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in mechanical engineering, electronic sensor integration, microfluidics, and pharmaceutical delivery systems, holding advanced degrees and 3-5 years of industry experience
Obviousness Rationale
A person having ordinary skill in the art would recognize that the source patent's mechanical dosage selection device naturally extends to more sophisticated electronic and AI-powered injection systems. The fundamental concept of precise dosage control and mechanical coupling is inherently scalable to advanced sensor and data-driven approaches. The PTD represents a predictable technological progression that combines known techniques in sensor integration, data analysis, and personalized medicine.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,708 |
|---|---|
| Title | Device for attachment to an injection device |
| Assignee(s) | Sanofi |